Cargando…

Cytokine profiles as markers of disease severity in sepsis: a multiplex analysis

INTRODUCTION: The current shortage of accurate and readily available, validated biomarkers of disease severity in sepsis is an important limitation when attempting to stratify patients into homogeneous groups, in order to study pathogenesis or develop therapeutic interventions. The aim of the presen...

Descripción completa

Detalles Bibliográficos
Autores principales: Bozza, Fernando A, Salluh, Jorge I, Japiassu, André M, Soares, Marcio, Assis, Edson F, Gomes, Rachel N, Bozza, Marcelo T, Castro-Faria-Neto, Hugo C, Bozza, Patrícia T
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2007
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2206478/
https://www.ncbi.nlm.nih.gov/pubmed/17448250
http://dx.doi.org/10.1186/cc5783
_version_ 1782148481428750336
author Bozza, Fernando A
Salluh, Jorge I
Japiassu, André M
Soares, Marcio
Assis, Edson F
Gomes, Rachel N
Bozza, Marcelo T
Castro-Faria-Neto, Hugo C
Bozza, Patrícia T
author_facet Bozza, Fernando A
Salluh, Jorge I
Japiassu, André M
Soares, Marcio
Assis, Edson F
Gomes, Rachel N
Bozza, Marcelo T
Castro-Faria-Neto, Hugo C
Bozza, Patrícia T
author_sort Bozza, Fernando A
collection PubMed
description INTRODUCTION: The current shortage of accurate and readily available, validated biomarkers of disease severity in sepsis is an important limitation when attempting to stratify patients into homogeneous groups, in order to study pathogenesis or develop therapeutic interventions. The aim of the present study was to determine the cytokine profile in plasma of patients with severe sepsis by using a multiplex system for simultaneous detection of 17 cytokines. METHODS: This was a prospective cohort study conducted in four tertiary hospitals. A total of 60 patients with a recent diagnosis of severe sepsis were included. Plasma samples were collected for measurement of cytokine concentrations. A multiplex analysis was performed to evaluate levels of 17 cytokines (IL-1β, IL-2, IL-4, IL-5, IL-6, IL-7, IL-8, IL-10, IL-12, IL-13, IL-17, interferon-γ, granulocyte colony-stimulating factor [G-CSF], granulocyte-macrophage colony-stimulating factor, monocyte chemoattractant protein [MCP]-1, macrophage inflammatory protein-1 and tumour necrosis factor-α). Cytokine concentrations were related to the presence of severe sepsis or septic shock, the severity and evolution of organ failure, and early and late mortality. RESULTS: Concentrations of IL-1β, IL-6, IL-7, IL-8, IL-10, IL-13, interferon-γ, MCP-1 and tumour necrosis factor-α were significantly higher in septic shock patients than in those with severe sepsis. Cytokine concentrations were associated with severity and evolution of organ dysfunction. With regard to the severity of organ dysfunction on day 1, IL-8 and MCP-1 exhibited the best correlation with Sequential Organ Failure Assessment score. In addition, IL-6, IL-8 and G-CSF concentrations during the first 24 hours were predictive of worsening organ dysfunction or failure of organ dysfunction to improve on day three. In terms of predicting mortality, the cytokines IL-1β, IL-4, IL-6, IL-8, MCP-1 and G-CSF had good accuracy for predicting early mortality (< 48 hours), and IL-8 and MCP-1 had the best accuracy for predicting mortality at 28 days. In multivariate analysis, only MCP-1 was independently associated with prognosis. CONCLUSION: In this exploratory analysis we demonstrated that use of a multiple cytokine assay platform allowed identification of distinct cytokine profiles associated with sepsis severity, evolution of organ failure and death.
format Text
id pubmed-2206478
institution National Center for Biotechnology Information
language English
publishDate 2007
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-22064782008-01-19 Cytokine profiles as markers of disease severity in sepsis: a multiplex analysis Bozza, Fernando A Salluh, Jorge I Japiassu, André M Soares, Marcio Assis, Edson F Gomes, Rachel N Bozza, Marcelo T Castro-Faria-Neto, Hugo C Bozza, Patrícia T Crit Care Research INTRODUCTION: The current shortage of accurate and readily available, validated biomarkers of disease severity in sepsis is an important limitation when attempting to stratify patients into homogeneous groups, in order to study pathogenesis or develop therapeutic interventions. The aim of the present study was to determine the cytokine profile in plasma of patients with severe sepsis by using a multiplex system for simultaneous detection of 17 cytokines. METHODS: This was a prospective cohort study conducted in four tertiary hospitals. A total of 60 patients with a recent diagnosis of severe sepsis were included. Plasma samples were collected for measurement of cytokine concentrations. A multiplex analysis was performed to evaluate levels of 17 cytokines (IL-1β, IL-2, IL-4, IL-5, IL-6, IL-7, IL-8, IL-10, IL-12, IL-13, IL-17, interferon-γ, granulocyte colony-stimulating factor [G-CSF], granulocyte-macrophage colony-stimulating factor, monocyte chemoattractant protein [MCP]-1, macrophage inflammatory protein-1 and tumour necrosis factor-α). Cytokine concentrations were related to the presence of severe sepsis or septic shock, the severity and evolution of organ failure, and early and late mortality. RESULTS: Concentrations of IL-1β, IL-6, IL-7, IL-8, IL-10, IL-13, interferon-γ, MCP-1 and tumour necrosis factor-α were significantly higher in septic shock patients than in those with severe sepsis. Cytokine concentrations were associated with severity and evolution of organ dysfunction. With regard to the severity of organ dysfunction on day 1, IL-8 and MCP-1 exhibited the best correlation with Sequential Organ Failure Assessment score. In addition, IL-6, IL-8 and G-CSF concentrations during the first 24 hours were predictive of worsening organ dysfunction or failure of organ dysfunction to improve on day three. In terms of predicting mortality, the cytokines IL-1β, IL-4, IL-6, IL-8, MCP-1 and G-CSF had good accuracy for predicting early mortality (< 48 hours), and IL-8 and MCP-1 had the best accuracy for predicting mortality at 28 days. In multivariate analysis, only MCP-1 was independently associated with prognosis. CONCLUSION: In this exploratory analysis we demonstrated that use of a multiple cytokine assay platform allowed identification of distinct cytokine profiles associated with sepsis severity, evolution of organ failure and death. BioMed Central 2007 2007-04-21 /pmc/articles/PMC2206478/ /pubmed/17448250 http://dx.doi.org/10.1186/cc5783 Text en Copyright © 2007 Bozza et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an open access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Bozza, Fernando A
Salluh, Jorge I
Japiassu, André M
Soares, Marcio
Assis, Edson F
Gomes, Rachel N
Bozza, Marcelo T
Castro-Faria-Neto, Hugo C
Bozza, Patrícia T
Cytokine profiles as markers of disease severity in sepsis: a multiplex analysis
title Cytokine profiles as markers of disease severity in sepsis: a multiplex analysis
title_full Cytokine profiles as markers of disease severity in sepsis: a multiplex analysis
title_fullStr Cytokine profiles as markers of disease severity in sepsis: a multiplex analysis
title_full_unstemmed Cytokine profiles as markers of disease severity in sepsis: a multiplex analysis
title_short Cytokine profiles as markers of disease severity in sepsis: a multiplex analysis
title_sort cytokine profiles as markers of disease severity in sepsis: a multiplex analysis
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2206478/
https://www.ncbi.nlm.nih.gov/pubmed/17448250
http://dx.doi.org/10.1186/cc5783
work_keys_str_mv AT bozzafernandoa cytokineprofilesasmarkersofdiseaseseverityinsepsisamultiplexanalysis
AT salluhjorgei cytokineprofilesasmarkersofdiseaseseverityinsepsisamultiplexanalysis
AT japiassuandrem cytokineprofilesasmarkersofdiseaseseverityinsepsisamultiplexanalysis
AT soaresmarcio cytokineprofilesasmarkersofdiseaseseverityinsepsisamultiplexanalysis
AT assisedsonf cytokineprofilesasmarkersofdiseaseseverityinsepsisamultiplexanalysis
AT gomesracheln cytokineprofilesasmarkersofdiseaseseverityinsepsisamultiplexanalysis
AT bozzamarcelot cytokineprofilesasmarkersofdiseaseseverityinsepsisamultiplexanalysis
AT castrofarianetohugoc cytokineprofilesasmarkersofdiseaseseverityinsepsisamultiplexanalysis
AT bozzapatriciat cytokineprofilesasmarkersofdiseaseseverityinsepsisamultiplexanalysis